ARCHIVES

Q & A: NCI’s Doroshow Says Phase I Program Will Stress Correlative Studies for Small Biotech Firms

This article is from The Cancer Letter archive.

Vol. 38 No. 14 | April 6, 2012

Download PDF Visit The Full Archive

Related Articles

In Brief: Mathews Could Help In Fighting OMB Obstruction Of Cancer Program; Easily Wins Senate Approval

August 1, 1975

In Brief: Tom Hall Names CMMI VP For Clinical Affairs; Rabson, Fauci Names to Institute Of Medicine

June 26, 1987

Garb’s Questions, Answers About Cancer Program

December 12, 1980

In Brief: Yarbro To Leave As NCI Centers Chief to Head Missouri Cancer Program; Replaced By Cantril

May 30, 1975

Kramer Says New Radiotherapy Could Save 1.3 Of Failures

February 18, 1977

Groups Advise NCI On “Investment Opportunities”

June 28, 1996